• How To Ensure Container Closure Integrity Of Combination Drug Products

    The rapidly increasing preference towards combination pharmaceutical products continues to fuel innovation, while presenting unique challenges in implementing a container closure integrity (CCI) testing strategy. Common examples of combination products include prefilled syringes, pen injectors, inhalers, and drug-eluting stents, orthopedic products, infusion pumps and more. The packaging for combination products can be just as complex as the products themselves. Hence, container closure integrity testing in line with current USP <1207> guidance and regulation is critical to ensure package integrity.

  • Applications For High Voltage Leak Detection You Might Not Be Aware Of

    High Voltage Leak Detection (HVLD), a technology first applied to pharmaceutical manufacturing in the 1970s, does not destructive to packaging components or cause the loss of good product like other inspection methods. HVLD is capable of handling any product as long as  the container is made of electrically insulated material and the product contains an electrically conductive solution. In this article you will learn more about other packaging applications that can be inspected with HVLD.

  • Six Mistakes Pharmaceutical Companies Make When Implementing Serialization

    This article examines mistakes that are commonly made in the planning and implementation phases of a serialization project, and proposes a solution to avoid each of these issues.

  • Evaluating Container Closure Integrity Of High-Risk Pharmaceuticals

    Since many high-risk pharmaceutical products are filled and sealed in combination devices, it’s critical for manufacturers to ensure that the components function well together. Hence, design and distribution considerations are critical to both the drug and the container. Manufacturing inconsistencies and tolerance differences in packages containing multiple components are primary contributors to distribution issues. Often, such inconsistencies result in container closure failure, causing serious implications down the supply chain. It is critical to use the most precise leak testing method possible.

  • Protecting Oxygen Sensitive Formulations Throughout Product Life Cycle

    The headspace gas composition in parenteral product containers is critical for sterile oxygen-sensitive drug product. This webinar reviews how oxygen levels in finished parenteral drug containers can be determined and controlled throughout the product life cycle by using laser-based headspace analysis. From development to manufacturing and QC, the optimization and control of oxygen levels can play an important role in achieving optimal shelf life and protecting drug efficacy.

  • Gene Therapy: Maintaining Sterility At Low Temperature Storage

    Bringing the first gene therapy for pediatric Spinal Muscular Atrophy to market in a leak and break resistant container which maintains sterility over product shelf life, through freeze and defrost cycles presented challenges. A combination of high-quality components created a proven system which ensured CCI over the product shelf life and low temperatures.

  • A Holistic Strategy To Ensure Container Closure Integrity Of Sterile Injectable Vial Product

    Recent regulatory guidance has triggered changes in industry best practices in the area of container closure integrity testing (CCIT). However, assuring good CCI of sterile injectable product goes beyond CCI testing. A more science-based holistic approach that includes robust design & qualification of the process and the implementation of appropriate process controls is required. This article describes a framework enabling such a holistic approach to CCI that assures both the primary packaging and the process contribute to good CCI of sterile injectable vial product.

  • Experimental Design And Statistical Tools For Non-Destructive Package Integrity Testing Systems

    This short podcast focuses on experimental design and statistical tools we use with non-destructive package integrity test systems. PTI’s Veripac inspection systems are deterministic test methods for package integrity testing that produce reliable and robust quantitative test data.

  • Package Inspection Guidelines For Sterile Medical Products

    Class III medical devices have a unique set of requirements and package characteristics that need a comprehensive approach to selecting the right inspection methods. A variety of inspection methods exist for medical package inspection that require a thorough understanding to ensure quality.


  • The HDC-4 offers 100% inspection for BFS large bottle production and non-destructive leak testing.

  • The HDK pinhole inspector for provides 100% inspection for IV Bags with non-destructive leak testing.

  • Packaging plays a significant role in the drug delivery system. Packaging provides information regarding the manufacturer’s name, price, date of manufacturing and expiry, dose or strength, ingredients, etc. Blister packaging is a type of packaging format specially designed for tablets and capsules made by heating and shaping a plastic sheet into the 'blister,' which is entirely covering the object, into a bubble or a pocket. Several types of plastic materials like Polyvinyl chloride (PVC), Polyethylene terephthalate (PET), Amorphous polyethylene terephthalate (APET), High-density polyethylene (HDPE), etc. and aluminum sheets or foils are used in blister packaging. Blister packages can offer barrier protection and some tamper resistance to shelf-life requirements.

  • Helium leak detection (HeLD) is routinely used and widely accepted for applications that require the utmost leak sensitivity. This brochure explains how Helium enables the discovery of extremely small microleaks that other leak testing methods cannot detect and what applications it can be used for.

  • Container Closure Integrity Testing of Pouches is common across many industries.